▲ XenoHelix has depleted its initial online launch inventory of the 'miPDRN 50K+ Serum' and has entered its second production round.

 

Bio and dermatological science specialist XenoHelix (CEO Sung-wook Yang) announced on September 14, 2026, that it has sold out its initial online launch inventory for the 'miPDRN 50K+ Serum' and has commenced a second production run.

The 'miPDRN 50K+ Serum' is a skincare product formulated with a 50,000 ppm concentration of ultra-low-molecular miPDRN, distinguishing it from conventional high-molecular PDRN. Utilizing the properties of this ultra-low-molecular material, it was developed as a serum optimized for skin delivery.

Following its launch on online channels, consumer response was much faster than anticipated, leading to the early depletion of the prepared initial inventory. XenoHelix is currently producing the second batch to minimize purchasing inconvenience and resume product supply swiftly.

 

The product's development utilized precise nucleic acid isolation and purification technology accumulated in the field of in vitro diagnostics. This is a technology that has been applied to handling ultra-low-molecular microRNA (miRNA) through a bio-platform that precisely isolates and purifies nucleic acids.

XenoHelix expanded this technology into cosmetic material research to realize miPDRN. The company highlights the integration of nucleic acid-related technology from the in vitro diagnostics field into skincare material development as the key differentiator of the product.

Moving forward, the company plans to continue its research on ultra-low-molecular PDRN materials and product development while promptly supplying the additionally produced volume.

 

An official from XenoHelix stated, "We are deeply grateful for the explosive response from consumers, who were the first to recognize the differentiated product capabilities of miPDRN, born from diagnostic-grade precision nucleic acid isolation technology." The official added, "To minimize customer inconvenience caused by the sudden sell-out, we have entered an emergency second round of additional production and will do our absolute best to supply the inventory quickly."

---